Insights

Innovative Therapy Pipeline BioMarin's focus on developing targeted therapies for rare genetic disorders presents opportunities to introduce complementary products or services that support genetic research, diagnostics, or personalized treatment plans, catering to their patient-centered approach.

Strategic Collaborations Recent mergers and integration activities, such as the partnership with Amicus Therapeutics, highlight BioMarin's openness to alliances. Business development can explore co-development, licensing, or distribution agreements in expanding rare disease markets.

Global Expansion Investment Significant investments in state-of-the-art facilities, including the €60 million expansion in Ireland, open avenues for supplying manufacturing, logistics, or regulatory consultancy services aligned with BioMarin’s international growth.

Recent Financial Activities BioMarin's recent issuance of new financing facilities and senior notes indicates liquidity and capacity for strategic investments, offering potential for financial partners or service providers involved in capital markets and treasury solutions.

Leadership and Innovation The appointment of a Chief Digital and Information Officer underscores a commitment to digital transformation; tech vendors and solution providers in areas like data management and digital health could align with their modernization initiatives.

BioMarin Pharmaceutical Inc Tech Stack

BioMarin Pharmaceutical Inc uses 8 technology products and services including Sitecore, Salesforce Health Cloud, Marketo, and more. Explore BioMarin Pharmaceutical Inc's tech stack below.

  • Sitecore
    Content Management System
  • Salesforce Health Cloud
    Electronic Health Records
  • Marketo
    Marketing Automation
  • LinkedIn
    Online Community Software
  • JSON
    Programming Languages
  • Planisware
    Project Management
  • ImageJ
    Software Development
  • Korber
    Supply Chain Management

Media & News

BioMarin Pharmaceutical Inc's Email Address Formats

BioMarin Pharmaceutical Inc uses at least 2 format(s):
BioMarin Pharmaceutical Inc Email FormatsExamplePercentage
First.Last@bmrn.comJohn.Doe@bmrn.com
64%
FLast@bmrn.comJDoe@bmrn.com
31%
Last.First@bmrn.comDoe.John@bmrn.com
2%
First.Middle@bmrn.comJohn.Michael@bmrn.com
1%
FiLast@bmrn.comJoDoe@bmrn.com
1%
FL@bmrn.comJD@bmrn.com
1%
First.Last@biomarin.comJohn.Doe@biomarin.com
87%
FLast@biomarin.comJDoe@biomarin.com
13%

Frequently Asked Questions

Where is BioMarin Pharmaceutical Inc's headquarters located?

Minus sign iconPlus sign icon
BioMarin Pharmaceutical Inc's main headquarters is located at 770 Lindaro Street San Rafael, California 94901 United States. The company has employees across 6 continents, including North AmericaEuropeSouth America.

What is BioMarin Pharmaceutical Inc's phone number?

Minus sign iconPlus sign icon
You can contact BioMarin Pharmaceutical Inc's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BioMarin Pharmaceutical Inc's stock symbol?

Minus sign iconPlus sign icon
BioMarin Pharmaceutical Inc is a publicly traded company; the company's stock symbol is BMRN.

What is BioMarin Pharmaceutical Inc's official website and social media links?

Minus sign iconPlus sign icon
BioMarin Pharmaceutical Inc's official website is biomarin.com and has social profiles on LinkedInCrunchbase.

How much revenue does BioMarin Pharmaceutical Inc generate?

Minus sign iconPlus sign icon
As of March 2026, BioMarin Pharmaceutical Inc's annual revenue is estimated to be $1.5B.

What is BioMarin Pharmaceutical Inc's SIC code NAICS code?

Minus sign iconPlus sign icon
BioMarin Pharmaceutical Inc's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BioMarin Pharmaceutical Inc have currently?

Minus sign iconPlus sign icon
As of March 2026, BioMarin Pharmaceutical Inc has approximately 3.2K employees across 6 continents, including North AmericaEuropeSouth America. Key team members include Chief Information Officer: E. V. P.Vice President Of Global Supply Chain: A. N.Vice President Human Resources, Global Technical Operations: M. L.. Explore BioMarin Pharmaceutical Inc's employee directory with LeadIQ.

What industry does BioMarin Pharmaceutical Inc belong to?

Minus sign iconPlus sign icon
BioMarin Pharmaceutical Inc operates in the Biotechnology Research industry.

What technology does BioMarin Pharmaceutical Inc use?

Minus sign iconPlus sign icon
BioMarin Pharmaceutical Inc's tech stack includes SitecoreSalesforce Health CloudMarketoLinkedInJSONPlaniswareImageJKorber.

What is BioMarin Pharmaceutical Inc's email format?

Minus sign iconPlus sign icon
BioMarin Pharmaceutical Inc's email format typically follows the pattern of First.Last@bmrn.com. Find more BioMarin Pharmaceutical Inc email formats with LeadIQ.

How much funding has BioMarin Pharmaceutical Inc raised to date?

Minus sign iconPlus sign icon
As of March 2026, BioMarin Pharmaceutical Inc has raised $586M in funding. The last funding round occurred on May 11, 2020 for $586M.

When was BioMarin Pharmaceutical Inc founded?

Minus sign iconPlus sign icon
BioMarin Pharmaceutical Inc was founded in 1997.

BioMarin Pharmaceutical Inc

Biotechnology ResearchCalifornia, United States1001-5000 Employees

Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of the genetic conditions that it seeks to treat, helping to better the lives of those struggling with rare genetic disease. BioMarin discoveries have led to eight first or best-in-class commercial treatments and a pipeline of multiple product candidates applying the same science-driven, patient-forward approach to broader group of genetic disorders. The more innovative solutions developed, the more lives BioMarin can impact.


Recruitment Fraud Alert Notice
 
Please be aware of fraud or scams from individuals, organizations and/or internet sites claiming to represent BioMarin in recruitment activities. We have an established recruitment process which is required for all posted positions by BioMarin prior to issuing an offer of employment. This BioMarin process requires formal interviews conducted live with personnel representing BioMarin and never requires payments or fees from job applicants. BioMarin does not conduct interviews via texting tools such as RingCentral.
 
In the event you receive a suspicious email message about recruiting on behalf of BioMarin, unless it’s from a BioMarin authorized recruiting partner, do not provide any personal information or pay any fees. Qualified and interested candidates should apply to current openings directly through this BioMarin website. BioMarin accepts no responsibility for any costs or charges incurred as a result of fraudulent activity.
 
If you have lost money or provided your personal identifying information, please contact your bank and report the matter to the FBI via www.ic3.gov. We would also suggest you notify your local police department and monitor your credit.

We appreciate your interest in BioMarin & encourage you to visit http://careers.biomarin.com/career-areas to review job opportunities.

Section iconCompany Overview

Headquarters
770 Lindaro Street San Rafael, California 94901 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
BMRN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1997
Employees
1001-5000

Section iconFunding & Financials

  • $586M

    BioMarin Pharmaceutical Inc has raised a total of $586M of funding over 1 rounds. Their latest funding round was raised on May 11, 2020 in the amount of $586M.

  • $1B$10B

    BioMarin Pharmaceutical Inc's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $586M

    BioMarin Pharmaceutical Inc has raised a total of $586M of funding over 1 rounds. Their latest funding round was raised on May 11, 2020 in the amount of $586M.

  • $1B$10B

    BioMarin Pharmaceutical Inc's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.